Skip to main content
. 2016 Jun 26;33:11–17. doi: 10.1007/8904_2016_576

Table 2.

Patient information

Patient Sex Age at diagnosis (months) GAA genotype CRIM status (Pos/Neg) Age ERT started (months) Immunomodulation (Y/N) Age at initial diagnostic VFSS (months) Age at the most recent assessment (months) Cardiac hypertrophy (LVMI, g/m2) Respiratory support Gross motor status
Start of ERT Recent assessment Start of ERT Recent assessment Start of ERT Recent assessment
1 F 4.9 c.784G > A / c.784G > A Pos 5 N 5.1 56 613 60 Oxy Nil Hypotonia Walking independently
2 M 0.4 c.2744A > C / c.2744A > C Pos 0.4 N N/A 89 96 48 Nil Nil Normal Walking independently
3 M 0.2 c.877G > A / c.877G > A Pos 2.2 Y 3.7 55 50.6 36 Nil nNIV Hypotonia Antigravity UL
4 F 6.2 c.2078dup / c.2078dup Neg 6.9 Y 6.6 24 773 55.7 Oxy cNIV Hypotonia Antigravity UL
5 M 6.9 n/a Pos NK N N/A 82 n/a 55.6 Nil Nil Hypotonia Walk with support (left hemiplegia from neonatal stroke)
6 M 3.1 c.1933G > A / c.1933G > A Pos 3.4 N 7 40 355 178.6 NIV Nil Hypotonia Walking independently
7 M 4.6 c.1933G > A / c.1933G > A Pos 4.8 N 5.3 20 114.3 49.8 Nil Nil Hypotonia Walking independently
8 M 6.2 c.2608C > T / c.2608C > T Neg 6.7 Y 6.3 19 367 128 Oxy cNIV Hypotonia UL + LL antigravity movements
9 M 6.4 c.1798C > T / c.2105G > T Pos 9.2 N 10.1 124 n/a 49.1 Nil Nil Hypotonia Bottom shuffling
10 F 5 c.2560C > T / c.2560C > T Neg 5.1 Y 4.9 40 665 69 Nil Nil Hypotonia Walking independently
11 M 3.6 c.525del / c.2481 + 102_c.2646 + 31del535 Neg 4 Y 4 44 343 60.2 Nil Vent Hypotonia Minimal movement UL
12 M 31.1a c.1082C > T / c.1933G > A Pos 31.2 N 29.8 144 140.4 70 nNIV nNIV Walk with support Walking independently

F female, M male, ERT enzyme replacement therapy, VFSS videofluoroscopy swallow study, CRIM cross-reactive immunologic material, NK not known, N/A not applicable, LVMI left ventricular mass index, Oxy oxygen, nNIV nocturnal non-invasive ventilation, cNIV continuous non-invasive ventilation, vent invasive ventilation, UL upper limbs, LL lower limbs

aPatient 12, classified as infantile onset as symptomatic with hypotonia, heart failure from 10.2 months age